Nhiễm Virus Viêm Gan Siêu Vi B Trước Đó Hoặc Tiềm Ẩn Trong Ung Thư Biểu Mô Gan Liên Quan Đến Virus Viêm Gan C Mà Không Có Xơ Gan

Sherlock S: Viruses and hepatocellular carcinoma. Gut 35:828–832, 1994 Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K: The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH 3T3 cells. Jpn J Cancer Res 80:617–621, 1989 Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH: Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9:1137–1145, 1990 Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320, 1991 Kalayci C, Johnson PJ, Davies SE, Williams R: Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol 12:54–59, 1991 Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, Ogura K, Niwa Y, Kawabe T, Omata M: Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 22:1027–1033, 1995 Blum HE, Liang TJ, Galun E, Wands JR: Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 14:56–62, 1991 Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R: Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 103:1649–1656, 1992 Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH: Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18:1313–1318, 1993 Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N: A molecular analysis of viral persistence in surface antigennegative chronic hepatitis B. Hepatology 23:389–395, 1996 Michalak TI, Pasquinelli C, Guilhot S, Chisari FV: Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 93:230–239, 1994 Rehermann B, Ferrari C, Pasquinelli C, Chisari FV: The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2:1104–1108, 1996 Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Bréchot C: Polymerase chain reaction to direct hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323:80–85, 1990 Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Wang JT, Lee PH, Lai MY, Wang CY, Yang PM, Lee HS, Chen DS: Hepatitis C and B viruses in hepatitis B surface antigennegative hepatocellular carcinoma. Gastroenterology 103: 1322–1327, 1992 Liang TI, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326–1333, 1993 Kobayashi S, Saigoh K, Urashima T, Asano T, Isono K: Significance of hepatitis B and hepatitis C viral sequences frequently detected in hepatocellular carcinoma tissues. Oncol Rep 1:1049–1053, 1994 Paterlini P, Poussin K, Kew M, Franco D, Brechot C: Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313–321, 1995 Edamoto Y, Tani M, Kurata T, Abe K: Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues. Cancer 77:1787–1791, 1996 Takeuchi M, Fujimoto J, Niwamoto H, Yamamoto Y, Okamoto E: Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci 42: 2264–2269, 1997 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Okuda T, Tamori A, Kuroki T, Kinoshita H: High prevalence of hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan. Hepatogastroenterology 46:357–359, 1999 Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orland ME, Raimondo G: Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22–26, 1999 Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M, IHIT Study Group: Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 131: 174–181, 1999 Herr W, Gerken G, Poralla T, Immenschuh S, Schirmacher P, Steegmüller KW, Schwickert H, Meyer zum Büschenfelde K-H: Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver. Clin Invest 71:49–53, 1993 De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Bréchot C, Paterlini P: HCV-associated liver cancer without cirrhosis. Lancet 345:413–415, 1995 El-Refaie, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, El-Batanony M, Soliman E-S, Nasr S, Mokhtar N, Amer K, Scheuer PJ, Dhillon AP: HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol 24:277–285, 1996 Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Fujimoto S, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S, Kuroki T: Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus. Hepatology 29:1429–1434, 1999 Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 92:1195–1203, 1996 Kubo S, Nishiguchi S, Tamori A, Hirohashi K, Kinoshita H, Kuroki T: Development of hepatocellular carcinoma in patients with hepatitis C virus infection, with or without past hepatitis B virus infection, and relationship to age at the time of blood transfusion. Vox Sang 74:129, 1998 Kubo S, Nishiguchi S, Hirohashi K, Shuto t, Kuroki T, Minamitani S, Ikebe T, Yamamoto T, Wakasa K, Kinoshita H: Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn J Cancer Res 89:419–426, 1998 Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M: The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study. J Exp Clin Cancer Res 18:379–389, 1999 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Yamamoto T, Ikebe T, Kinoshita H: Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 86:793–798, 1999 Edmondson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7:462–503, 1954 Liver Cancer Study Group of Japan: Classification of Primary Liver Cancer, 1st ed. Tokyo, Kanehara & Co., 1997 Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation on application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513–1520, 1994 Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987 Fujiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K: Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res 11:4601–4610, 1983 Liver Cancer Study Group of Japan: Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287, 1990 Sato A, Kato Y, Nakata K, Nakao K, Daikoku M, Ishii N, Matsumoto T, Iseki K, Mazume H, Nagataki S: Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus-and hepatitic C virus-associated cirrhosis. J Gastroenterol Hepatol 11:944–948, 1996 Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni Y, Okamoto N, Inoue T, Kanisawa M: Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology 103:595–600, 1992 Kubo S, Tamori A, Omura T, Ikebe T, Wakasa K, Hirohashi K, Kinoshita H, Otani S: Ornithine decarboxylase activity in the noncancerous hepatic tissue of patients with hepatocellular carcinoma. Hepatogastroenterology 47:820–823, 2000 Kubo S, Yamamoto T, Ikebe T, Shuto T, Hirohashi K, Tanaka H, Tsukamoto T, Wakasa K, Kinoshita H: Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C. Jpn J Cancer Res 90:1076–1080, 1999 Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koike Y, Asano T, Kondo Y, Koike K, Isono K: Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J Hepatol 26:771–778, 1997 Wang W, London WT, Feitelson MA: Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51:4971–4977, 1991 Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Jones R, Borkowski A, Harris CC: Integrity of p53 in hepatitis B _ antigen-positive and-negative hepatocellular carcinomas. Cancer Res 57:426–432, 1997 Feitelson MA, Zhu M, Duan LX, London WT: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117, 1993 Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9:41–47, 1995 Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC: Hepatitis B virus x protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 94: 14707–14712, 1997 Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065–1067, 1998 Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T: High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 45:284–288, 1999